| 1 |
oxidized low-density lipoprotein
(3504 times)
|
Biochemistry
(665 times)
|
HUVECs (285 times)
ROS (265 times)
AS (251 times)
|
1989 Protective role of intracellular glutathione against oxidized low density lipoprotein in cultured endothelial cells.
|
| 2 |
oxidised LDL
(27 times)
|
Nutritional Sciences
(5 times)
|
LDL (8 times)
HDL (3 times)
ET-1 (2 times)
|
1990 Native and oxidized low-density lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in the rabbit aorta.
|
| 3 |
oxidized low-density lipoprotein cholesterol
(25 times)
|
Pharmacology
(4 times)
|
LOX-1 (3 times)
VCAM-1 (3 times)
ABC (2 times)
|
2003 [Effect of oxidated low-density lipoprotein on early apoptosis of vascular smooth muscle cell].
|
| 4 |
oxidative LDL
(3 times)
|
Chemistry, Clinical
(1 time)
|
LDL (3 times)
ADMA (1 time)
CGN (1 time)
|
2001 Serum lipid metabolism abnormalities and change in lipoprotein contents in patients with advanced-stage renal disease.
|
| 5 |
oxidized LDL lipids
(2 times)
|
Sports Medicine
(1 time)
|
HDL-C (1 time)
LDL-C (1 time)
s-TRAP (1 time)
|
2012 Decreased training volume and increased carbohydrate intake increases oxidized LDL levels.
|
| 6 |
oxidation Low Lipoprotein
(1 time)
|
Cardiology
(1 time)
|
IL (1 time)
miRNA-640 (1 time)
TNF-alpha (1 time)
|
2020 Hsa_circ_0001445 inhibits ox-LDL-induced HUVECs inflammation, oxidative stress and apoptosis by regulating miRNA-640.
|
| 7 |
oxidative damage of low density lipoproteins
(1 time)
|
Geriatrics
(1 time)
|
AD (1 time)
PAF-AH (1 time)
PON1 (1 time)
|
2015 Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer's Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1.
|
| 8 |
Oxidative modification of LDL
(1 time)
|
Biochemistry
(1 time)
|
ASCVD (1 time)
CMA (1 time)
LDL-C (1 time)
|
2021 The Effects of Statin Dose, Lipophilicity, and Combination of Statins plus Ezetimibe on Circulating Oxidized Low-Density Lipoprotein Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
|
| 9 |
oxidative stress induced by low-density lipoprotein
(1 time)
|
Biochemistry
(1 time)
|
GSH-Px (1 time)
HFD (1 time)
HO-1 (1 time)
|
2018 iRhom2 promotes atherosclerosis through macrophage inflammation and induction of oxidative stress.
|
| 10 |
oxidized form of LDL-cholesterol
(1 time)
|
Medicine
(1 time)
|
LDL (1 time)
SR (1 time)
|
2011 Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy.
|
| 11 |
oxidized liporoptein cholesterol
(1 time)
|
Cardiology
(1 time)
|
PCSK9 (1 time)
SRs (1 time)
TNF-alpha (1 time)
|
2018 PCSK9 regulates expression of scavenger receptors and ox-LDL uptake in macrophages.
|
| 12 |
oxidized low-density cholesterol
(1 time)
|
Complementary Therapies
(1 time)
|
AMPK (1 time)
CAD (1 time)
LOX1 (1 time)
|
2019 Effects of crocin and saffron aqueous extract on gene expression of SIRT1, AMPK, LOX1, NF-kappaB, and MCP-1 in patients with coronary artery disease: A randomized placebo-controlled clinical trial.
|
| 13 |
oxidized low-density lipoprotein antibodies
(1 time)
|
Vascular Diseases
(1 time)
|
aCL (1 time)
aPL (1 time)
APS (1 time)
|
2010 Antiphospholipid antibodies and antiphospholipid syndrome: role in portal vein thrombosis in patients with and without liver cirrhosis.
|
| 14 |
oxidized macromolecules, especially low-density lipoproteins
(1 time)
|
Medicine
(1 time)
|
HDL (1 time)
PCR-RFLP (1 time)
PON1 (1 time)
|
2013 Genetic polymorphisms of paraoxonase 1 and susceptibility to atherogenesis.
|
| 15 |
oxidized modified LDL
(1 time)
|
Vascular Diseases
(1 time)
|
ceRNA (1 time)
HAVSMCs (1 time)
LDL (1 time)
|
2021 SNHG12 regulates biological behaviors of ox-LDL-induced HA-VSMCs through upregulation of SPRY2 and NUB1.
|
A Search Service for Abbreviation / Long Form